Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vets to debate how to engage Gen Z in disease prevention
"It is essential the profession understands this grwing demand and ensures pet owners have access to accurate information" - Justine Shotton, BVA vice-president.
The BVA Congress session will explore the challenges and opportunities for reaching a younger generation of pet owner.

A panel debate exploring how to reach a younger generation of pet owners to prevent disease will take place at London Vet Show on Friday (18 November).

The BVA Congress session, titled Preventative Health and the Gen Z Client – engaging a new generation of pet owners with disease prevention, will explore the issues and opportunities presented by this new, tech-savvy generation.

Chaired by BVA senior vice president Justine Shotton, the session will look at how young people access, digest and share information in new ways. 

Joining her on the panel will be Tanya Michelsen, associate director of CM Research; Marnie Brennan, associate professor in epidemiology at the University of Nottingham; Rebekah Ellis, brand and customer manager, MSD Human Health, and Ben Sweeney, founder and CEO of Vidivet.

Dr Shotton said: “The rapid proliferation of telemedicine and the growth of online advice groups on platforms like Facebook are clear signs that clients are looking for additional ways to access veterinary services and advice. 

“It is essential the profession understands this growing demand and ensures pet owners have access to accurate information. This session at BVA Congress promises to be extremely insightful, exploring the challenges but also the opportunities for reaching a new, younger generation of pet owner.” 

The session takes place on Friday, 18 November, 1:50 pm.

Become a member or log in to add this story to your CPD history

Antibiotic Amnesty survey opens

News Story 1
 The Responsible Use of Medicines Alliance - Companion Animal and Equine (RUMA - CA&E) has launched a survey which seeks to measure the success of this year's Antibiotic Amnesty campaign.

Its results will help the group to calculate how many unused or out-of-date antibiotics were returned as part of the campaign throughout November. Practices are also asked how they engaged with clients to raise awareness of the issue.

Participating practices can enter a prize draw to win up to 100 in vouchers for taking part. Further prizes from BSAVA and Webinar Vet will be available for practices with the best input.

The survey takes a few minutes to complete and will be running throughout December. It can be accessed via this link

Click here for more...
News Shorts
Bluetongue cases lead to restricted zone extension

Following the detection of new cases of bluetongue virus serotype 3 (BTV-3), the restricted zone has been extended to include additional parts of Hampshire, Wiltshire, Oxfordshire and North Yorkshire, as well as Bournemouth, Christchurch, Poole and part of Dorset.

The zone now covers 28 counties and unitary authorities in England. As of 16 December, 185 cases of BTV-3 have been confirmed in England and Wales during the current vector period.

Bluetongue is a notifiable disease. Suspected cases must be reported on 03000 200 301 in England or 03003 038 268 in Wales. In Scotland, suspected cases should be reported to the local field services office. Suspected cases in Northern Ireland should be reported to the DAERA Helpline on 0300 200 7840 or by contacting the local DAERA Direct Veterinary Office.

A map of the area where movement restrictions apply can be found here.